VC-backed EndoStim pulls IPO

By Iris Dorbian — 2 months ago

According to an SEC filing, St.Louis, Missouri and Netherlands-based EndoStim, which focuses on treating acid reflux, has withdrawn its planned IPO. The reason given was “market conditions.” Its backers include Santé Ventures, Prolog Ventures and Vectis Healthcare & Life Sciences Fund.


EndoStim Raises $6 Million

By PEHub Administrator — 6 years ago

EndoStim Inc., a St Louis-based developer of minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, has raised $6 million in Series B funding. Santé Ventures led the round, and was joined by Prolog Ventures, Vectis Healthcare & Life Sciences Fund and individual angels.